GL1X · GenesisL1 explorer

MolNFT v1 · #135084 · protein

Selectivity switch between fak and PYK2: macrocyclization of fak inhibitors improves PYK2 potency

5TO8 · Protein-tyrosine kinase 2-beta: “Selectivity switch between fak and PYK2: macrocyclization of fak inhibitors improves PYK2 potency”. X-ray diffraction, 1 ligand (7FM), 2 pockets (best druggability 0.66). MolNFT v1 #135084 on…

PDB
5TO8
Type
protein
Length
250 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein-tyrosine kinase 2-beta
EC
2.7.10.2
UniProt
Q14289
Ligands
7FM
Pockets
2 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein-tyrosine kinase 2-beta (EC 2.7.10.2)protein25043% helix, 20% strandQ14289

Ligands and binding sites

  • 7FM · 25-(methylsulfonyl)-8-(trifluoromethyl)-5,17,18,21,22, 23,24,25-octahydro-12H-7,11-(azeno)-16,13-(metheno) pyrido[3,2-i]pyrrolo[1,2-Q][1,3,7,11, 17]pentaazacyclohenicosin-20(6H)-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13060.660.81377FM
2750.390.7814empty

Compared structures

  • Q14289 · AlphaFold monomer V2.0 prediction for protein-tyrosine kinase 2-beta (Q14289) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.